TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy.

Bradley J Monk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.